eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2022
vol. 8
 
Share:
Send email
Share:
abstract:
Review paper

Coagulation disorders and vascular diseases of the liver in patients with COVID-19

Maria Tsafaridou
1
,
Ilianna Maniadaki
2
,
Ioannis Koutroubakis
1
,
Dimitrios N. Samonakis
1

  1. Department of Gastroenterology and Hepatology, University Hospital of Heraklion, Crete, Greece
  2. Department of Pediatrics, University Hospital of Heraklion, Crete, Greece
Clin Exp HEPATOL 2022; 8, 2: 97-102
DOI: https://doi.org/10.5114/ceh.2022.116972
Online publish date: 2022/06/14
View full text Get citation
 
PlumX metrics:
The current coronavirus disease 2019 (COVID-19) pandemic has caused a global health emergency crisis, since its outbreak at the end of 2019. Although it mainly affects the respiratory system, it is documented that several important extrapulmonary manifestations exist in the context of the COVID-19 infection. Amongst the major pathophysiological mechanisms, the generation of a prothrombotic environment is increasingly recognized and is related to thromboembolic events. We conducted a review of the literature and summarized the coagulation disorders in the liver in patients with COVID-19.
keywords:

COVID-19, liver, thrombosis, portal vein
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.